LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This filing is a Current Report on Form 8-K dated June 9, 2021, regarding the results of LivaNova PLC's 2021 Annual General Meeting (AGM). The meeting was held virtually on June 9, 2021. A total of 43,129,248 ordinary shares, representing 88.28% of shares eligible to vote, were present, constituting a quorum.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
All nine proposals presented to shareholders were adopted. Key outcomes include:
- Director Elections: All ten nominees were elected to the Board of Directors for a term expiring at the 2022 AGM. Vote counts ranged from approximately 39.4 million to 41.8 million votes in favor.
- Executive Compensation: Shareholders approved the "Say-on-Pay" advisory resolution for Named Executive Officers with 37,971,805 votes for and 3,915,484 votes against.
- Auditor Ratification: PricewaterhouseCoopers LLP (PwC USA) was ratified as the independent registered public accounting firm, and PwC (UK) was re-appointed as the UK statutory auditor.
- Share Issuance Authority: Directors were authorized to allot shares up to a nominal amount of £16,122,679. Additionally, a special resolution empowered directors to allot equity securities for cash up to £2,442,830 for general purposes and an additional £2,442,830 specifically for financing acquisitions or capital investments, bypassing pre-emption rights.
- Financial Statements: The audited UK statutory accounts for the year ended December 31, 2020, were received and adopted.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It is a procedural report confirming the successful passage of standard corporate governance resolutions.
Key Facts for Investor Verification
- Verify the specific terms of the share issuance authority (up to £16.1 million nominal value) and the pre-emption rights waiver (up to £4.9 million nominal value total) granted to the Board.
- Confirm the re-election of the full slate of ten directors, noting the specific vote counts for each nominee.
- Review the 2021 Proxy Statement for detailed descriptions of the nine proposals summarized in this filing.
- Note that the audited financial statements for the fiscal year ended December 31, 2020, were formally adopted at this meeting.